Monday, November 25, 2024
HomeTagsTempus

Tag: Tempus

spot_imgspot_img

Tempus Announces Collaboration With JW Pharmaceutical

Tempus, a leader in artificial intelligence and precision medicine, announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea,...

Tempus Announces the Clinical Launch of its MRD Testing Portfolio

xM MRD and NeXT Personal Dx tests are now available for physicians in the U.S. for early cancer recurrence detection and residual disease monitoring Tempus,...

Tempus Releases New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2-Directed Antibody-Drug Conjugates in Several Tumor...

Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract,...

Tempus Introduces Workspaces into its Lens Data Analytics Platform

Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform. Workspaces is a private,...

Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna

Tempus, a leader in artificial intelligence and precision medicine, announced that the company has signed an agreement for in-network provider status with Cigna Healthcare....

Tempus Introduces AI-enabled Assistant, Tempus One, Into Lens Data Analytics Platform to Accelerate Research

Tempus, a leader in artificial intelligence and precision medicine, announced the integration of its signature Tempus One technology into its Lens data analytics platform....

Tempus Introduces xM to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only

Tempus, a leader in artificial intelligence and precision medicine, announced the addition of a novel MRD assay, xM, to its comprehensive testing solutions. The...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

[tds_leads input_placeholder=”Your email address” btn_horiz_align=”content-horiz-center” pp_msg=”SSd2ZSUyMHJlYWQlMjBhbmQlMjBhY2NlcHQlMjB0aGUlMjAlM0NhJTIwaHJlZiUzRCUyMiUyMyUyMiUzRVByaXZhY3klMjBQb2xpY3klM0MlMkZhJTNFLg==” pp_checkbox=”yes” tdc_css=”eyJhbGwiOnsibWFyZ2luLXRvcCI6IjMwIiwibWFyZ2luLWJvdHRvbSI6IjQwIiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tdG9wIjoiMTUiLCJtYXJnaW4tYm90dG9tIjoiMjUiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3NjgsImxhbmRzY2FwZSI6eyJtYXJnaW4tdG9wIjoiMjAiLCJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sImxhbmRzY2FwZV9tYXhfd2lkdGgiOjExNDAsImxhbmRzY2FwZV9taW5fd2lkdGgiOjEwMTksInBob25lIjp7Im1hcmdpbi10b3AiOiIyMCIsImRpc3BsYXkiOiIifSwicGhvbmVfbWF4X3dpZHRoIjo3Njd9″ display=”column” gap=”eyJhbGwiOiIyMCIsInBvcnRyYWl0IjoiMTAiLCJsYW5kc2NhcGUiOiIxNSJ9″ f_msg_font_family=”downtown-sans-serif-font_global” f_input_font_family=”downtown-sans-serif-font_global” f_btn_font_family=”downtown-sans-serif-font_global” f_pp_font_family=”downtown-serif-font_global” f_pp_font_size=”eyJhbGwiOiIxNSIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_weight=”700″ f_btn_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTEifQ==” f_btn_font_transform=”uppercase” btn_text=”Unlock All” btn_bg=”#000000″ btn_padd=”eyJhbGwiOiIxOCIsImxhbmRzY2FwZSI6IjE0IiwicG9ydHJhaXQiOiIxNCJ9″ input_padd=”eyJhbGwiOiIxNSIsImxhbmRzY2FwZSI6IjEyIiwicG9ydHJhaXQiOiIxMCJ9″ pp_check_color_a=”#000000″ f_pp_font_weight=”600″ pp_check_square=”#000000″ msg_composer=”” pp_check_color=”rgba(0,0,0,0.56)” msg_succ_radius=”0″ msg_err_radius=”0″ input_border=”1″ f_unsub_font_family=”downtown-sans-serif-font_global” f_msg_font_size=”eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_size=”eyJhbGwiOiIxNCIsInBvcnRyYWl0IjoiMTIifQ==” f_input_font_weight=”500″ f_msg_font_weight=”500″ f_unsub_font_weight=”500″]

Must read

spot_img